​

Funding Round

Series B - Cognito Therapeutics

Series B - Cognito Therapeutics

Investment Firm

Overview

Cognito Therapeutics is a neurotechnology company that is developing disease-modifying treatments for CNS illnesses.

Announced Date

Mar 22, 2023

Funding Type

Series B

Highlights

Location

United States, North America

Social

Investor Lead

FoundersX Ventures

FoundersX Ventures

FoundersX Ventures is a early_stage_venture and seed firm.

Participant Investors

5

Investor Name
Participant InvestorStarbloom Capital
Participant InvestorMorningside Venture Investments
Participant InvestorIAG Capital Partners
Participant InvestorFoundersX Ventures
Participant InvestorAlzheimer's Drug Discovery Foundation

Round Details and Background

Cognito Therapeutics raised $73000000 on 2023-03-22 in Series B

Cognito Therapeutics is a neurotechnology company that is developing disease-modifying treatments for CNS illnesses.

Company Funding History

3

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Mar 22, 2023
Series B - Cognito Therapeutics
6-73.0M
Jun 27, 2022
Venture Round - Cognito Therapeutics
1-108.8M
Jan 29, 2024
Series B - Cognito Therapeutics
1-35.0M

Recent Activity

There is no recent news or activity for this profile.